Literature DB >> 19723109

Involvement of reactive oxygen species in apoptosis induced by pharmacological inhibition of protein kinase CK2.

Ismail M Hanif1, Kashif A Ahmad, Khalil Ahmed, Shazib Pervaiz.   

Abstract

It has been reported that inhibition of protein kinase CK2 (CK2) with antisense oligodeoxynucleotides (ODN) is a potent inducer of apoptosis in cancer cells but not in normal cells. In this regard, the apoptotic-inducing effect is attributed to the catalytic activity of the enzyme, which phosphorylates proapoptotic proteins to inhibit their functions. In this study we investigate the role of intracellular redox status in the proapoptotic activity of CK2 inhibition in human leukemia Cem cells. We provide evidence that inhibition of CK2 activity induces apoptotic cell death as evident by activation of caspase 3, DNA fragmentation, and phosphatidylserine externalization. Inhibition of CK2 resulted in a significant increase in intracellular hydrogen peroxide production, which we show as a critical mediator of apoptosis. To that end, apoptotic hallmarks, like DNA fragmentation and phosphatidylserine externalization, were blocked with the specific hydrogen peroxide scavenger catalase. We also show that inhibition of CK2 reduces cytosolic intracellular superoxide, a precursor of hydrogen peroxide. In summary, decreasing CK2 activity increases intracellular hydrogen peroxide, creating an intracellular environment conducive for death execution. Taken together, these data provide information on novel pathways involved in CK2 biology with implications for effective tools against drug-resistant tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723109      PMCID: PMC4392777          DOI: 10.1111/j.1749-6632.2009.04916.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  33 in total

1.  Intracellular superoxide and hydrogen peroxide concentrations: a critical balance that determines survival or death.

Authors:  M V Clément; S Pervaiz
Journal:  Redox Rep       Date:  2001       Impact factor: 4.412

2.  Hydrogen peroxide-induced apoptosis: oxidative or reductive stress?

Authors:  Shazib Pervaiz; Marie-Véronique Clément
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

Review 3.  Using chemopreventive agents to enhance the efficacy of cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

4.  Oxidative stress and tumour cell proliferation.

Authors:  R H Burdon; V Gill; C Rice-Evans
Journal:  Free Radic Res Commun       Date:  1990

Review 5.  Prooxidant states and tumor promotion.

Authors:  P A Cerutti
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

6.  Cell proliferation and oxidative stress.

Authors:  R H Burdon; V Gill; C Rice-Evans
Journal:  Free Radic Res Commun       Date:  1989

7.  Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells.

Authors:  J L Hirpara; M V Clément; S Pervaiz
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

Review 8.  Protein kinase CK2 signal in neoplasia.

Authors:  S Tawfic; S Yu; H Wang; R Faust; A Davis; K Ahmed
Journal:  Histol Histopathol       Date:  2001-04       Impact factor: 2.303

9.  2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.

Authors:  Mario A Pagano; Flavio Meggio; Maria Ruzzene; Mariola Andrzejewska; Zygmunt Kazimierczuk; Lorenzo A Pinna
Journal:  Biochem Biophys Res Commun       Date:  2004-09-03       Impact factor: 3.575

10.  Superoxide anion is a natural inhibitor of FAS-mediated cell death.

Authors:  M V Clément; I Stamenkovic
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

View more
  4 in total

Review 1.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

2.  Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in Mice.

Authors:  Ayumi Hashimoto; Chan Gao; Jerome Mastio; Andrew Kossenkov; Scott I Abrams; Ashok V Purandare; Heshani Desilva; Susan Wee; John Hunt; Maria Jure-Kunkel; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2018-08-23       Impact factor: 12.701

3.  Protein kinase CK2 inhibition induces cell death via early impact on mitochondrial function.

Authors:  Fatima Qaiser; Janeen H Trembley; Betsy T Kren; Jing-Jiang Wu; A Khaliq Naveed; Khalil Ahmed
Journal:  J Cell Biochem       Date:  2014-12       Impact factor: 4.429

Review 4.  CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.

Authors:  Janeen H Trembley; Betsy T Kren; Md Joynal Abedin; Rachel I Vogel; Claire M Cannon; Gretchen M Unger; Khalil Ahmed
Journal:  Pharmaceuticals (Basel)       Date:  2017-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.